Resmed (RMD) Tax Provisions (2009 - 2026)

Resmed (RMD) has 18 years of Tax Provisions data on file, last reported at $103.6 million in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions rose 96.73% year-over-year to $103.6 million; the trailing twelve-month figure through Mar 2026 stood at $383.7 million (up 45.36% YoY), and the FY2025 full-year result was $276.8 million, up 13.53% from the prior year.
• Tax Provisions for Q1 2026 stood at $103.6 million, roughly flat from $103.6 million in the prior quarter.
• Across five years, Tax Provisions topped out at $103.6 million in Q1 2026 and bottomed at $43.0 million in Q2 2022.
• The 5-year median for Tax Provisions is $56.9 million (2023), against an average of $65.9 million.
• The widest annual swing landed in 2022, when Tax Provisions tumbled 84.04%; it then jumped 96.73% in 2026.
• A 5-year view of Tax Provisions shows it stood at $48.8 million in 2022, then increased by 3.85% to $50.7 million in 2023, then jumped by 45.5% to $73.7 million in 2024, then soared by 40.51% to $103.6 million in 2025, then gained by 0.02% to $103.6 million in 2026.
• The last three Tax Provisions figures came in at $103.6 million (Q1 2026), $103.6 million (Q4 2025), and $98.3 million (Q3 2025), per Business Quant data.

Peer Comparison